NOVARTIS NAM. SF 0,49/ CH0012005267 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 217.08 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 7.15 USD | 124.14% |
| EPS Diluted: | - USD | 123.97% |
| Revenues per Share: | 20.49 USD | -14.09% |
| Book Value per Share: | 20.49 USD | -26.91% |
| Cash Flow per Share: | 6.35 USD | 227.31% |
| Dividend per Share: | 3.90 USD | 4.00% |
| Total | in mill. | |
| Revenues: | 46,660.00 USD | -7.69% |
| Net Income: | 14,850.00 USD | 113.52% |
| Operating Cash Flow: | 14,458.00 USD | - |
| Cash and Cash Equivalents: | 13,393.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 14.42 | 14.06 |
| P/S Ratio: | 5.03 | 4.91 |
| P/BV ratio: | 5.03 | 4.91 |
| P/CF Ratio: | 16.24 | 15.84 |
| PEG: | 0.12 | 0.11 |
| Earnings Yield: | 6.93% | 7.11% |
| Dividend Yield: | 3.78% | 3.88% |
| Market Capitalization | ||
| Market Capitalization: | 217.08 bill. EUR | 207.39 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 2.85 mill. EUR | 2.73 mill. EUR |
| Shares Outstanding: | 2.06 bill. | |
Profitability
| Gross Profit Margin: | 73.27% |
| EBIT Margin: | 20.94% |
| Net Profit Margin: | 31.83% |
| Return on Equity: | 31.82% |
| Return on Assets: | 14.86% |
Financial Strength
| Liquidity I / Cash Ratio: | 50.75% |
| Liquidity II / Quick Ratio: | 77.68% |
| Liquidity III / Current Ratio: | 115.50% |
| Debt / Equity Ratio: | 114.17% |
| Dynam. Debt / Equity Ratio: | 368.50% |
Efficiency
| Employees: | 76,057 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 613,487.25 USD |
| Net Income / Employee: | 195,248.30 USD |
| Total Assets / Employee: | 1,314,080.23 USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | USD |
